Charles River Laboratories International, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Charles River Laboratories International, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4466
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:63
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥22,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥45,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥68,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Charles River Laboratories International, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Charles River Laboratories International, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Charles River Laboratories International, Inc. (CRL or ‘the company’) is a full service, early-stage contract research organization. Its core competencies and research model technologies allows it to develop a range of discovery and safety assessment services in both GLP and non-GLP standards. In addition, it provides various services related to clients manufacturing activities. These include basic research services (research animal models, surgical services, genetic testing services, colony management services, health monitoring services), drug discovery and safety assessment services, clinical support services, operations and staffing support services, and manufacturing support services (endotoxin and microbial detection, biologics testing solutions, and avian vaccine services). The company operates in the US, Europe, Japan, Canada and other regions of the world. CRL is headquartered in Wilmington, Massachusetts, the US.

Scope

- Detailed information on Charles River Laboratories International, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Charles River Laboratories International, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Charles River Laboratories International, Inc. including a breakdown and examination of key business segments
- Intelligence on Charles River Laboratories International, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Charles River Laboratories International, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Charles River Laboratories International, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Charles River Laboratories International, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Charles River Laboratories International, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Charles River Laboratories International, Inc.: Company Overview 9
Charles River Laboratories International, Inc.: Overview and Key Facts 9
Charles River Laboratories International, Inc.: Overview 9
Charles River Laboratories International, Inc.: Key Facts 9
Charles River Laboratories International, Inc.: Key Employees 11
Charles River Laboratories International, Inc.: Key Employee Biographies 13
Charles River Laboratories International, Inc.: Major Products and Services 20
Charles River Laboratories International, Inc.: Company History 21
Charles River Laboratories International, Inc.: Management Statement 26
Charles River Laboratories International, Inc.: Locations and Subsidiaries 30
Charles River Laboratories International, Inc.: Key Competitors 31
Charles River Laboratories International, Inc.: Company Analysis 32
Charles River Laboratories International, Inc.: Business Description 32
Charles River Laboratories International, Inc.: SWOT Analysis 34
Charles River Laboratories International, Inc.: SWOT Overview 34
Charles River Laboratories International, Inc.: Strengths 34
Charles River Laboratories International, Inc.: Weaknesses 35
Charles River Laboratories International, Inc.: Opportunities 35
Charles River Laboratories International, Inc.: Threats 38
Charles River Laboratories International, Inc.: Corporate Financial Deals Activity 40
Charles River Laboratories International, Inc.: Financial Deals Overview 40
Charles River Laboratories International, Inc.: Targets and Partners 42
Charles River Laboratories International, Inc.: Top Deals 2014 – 2018YTD* 44
Charles River Laboratories International, Inc.: Advisors 45
Charles River Laboratories International, Inc.: Top Legal Advisors 45
Charles River Laboratories International, Inc.: Top Financial Advisors 45
Charles River Laboratories International, Inc.: Mergers and Acquisitions 46
Charles River Laboratories International, Inc.: Corporate Venturing 47
Charles River Laboratories International, Inc.: Capital Raising 48
Charles River Laboratories International, Inc.: Partnership 49
Charles River Laboratories International, Inc.: Divestments 50
Charles River Laboratories International, Inc.: Recent Developments 51
Charles River Laboratories International, Inc.: News and Events Summary 51
Charles River Laboratories International, Inc.: Business Expansion 56
Charles River Laboratories International, Inc.: Contracts 57
Charles River Laboratories International, Inc.: Corporate Governance 58
Charles River Laboratories International, Inc.: Financial Performance 58
Charles River Laboratories International, Inc.: Market Developments 58
Charles River Laboratories International, Inc.: Strategy and Operations 60
Appendix 61
Contact Us 61
Methodology 61
About MarketLine 62

List of Tables
Table 1: Charles River Laboratories International, Inc.: Key Facts
Table 2: Charles River Laboratories International, Inc.: Key Employees
Table 3: Charles River Laboratories International, Inc.: Locations and Subsidiaries
Table 4: Charles River Laboratories International, Inc.: Key Competitors
Table 5: Charles River Laboratories International, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Charles River Laboratories International, Inc.: M&A Activity by Geography (TTM*)
Table 7: Charles River Laboratories International, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Charles River Laboratories International, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Charles River Laboratories International, Inc.: Targets and Partners
Table 10: Charles River Laboratories International, Inc.: Top Deals 2014 - 2018YTD*
Table 11: Charles River Laboratories International, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Charles River Laboratories International, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Charles River Laboratories International, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Charles River Laboratories International, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Charles River Laboratories International, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 16: Charles River Laboratories International, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 17: Charles River Laboratories International, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 18: Charles River Laboratories International, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 19: Charles River Laboratories International, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 20: Charles River Laboratories International, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 21: Charles River Laboratories International, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 22: Charles River Laboratories International, Inc.: News and Events Summary
Table 23: Charles River Laboratories International, Inc.: Business Expansion
Table 24: Charles River Laboratories International, Inc.: Contracts
Table 25: Charles River Laboratories International, Inc.: Corporate Governance
Table 26: Charles River Laboratories International, Inc.: Financial Performance
Table 27: Charles River Laboratories International, Inc.: Market Developments
Table 28: Charles River Laboratories International, Inc.: Strategy and Operations

List of Figures
Figure 1: Charles River Laboratories International, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Charles River Laboratories International, Inc.: M&A Activity by Geography (TTM*)
Figure 3: Charles River Laboratories International, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Charles River Laboratories International, Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Charles River Laboratories International, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Charles River Laboratories International, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Charles River Laboratories International, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Charles River Laboratories International, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Charles River Laboratories International, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 10: Charles River Laboratories International, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 11: Charles River Laboratories International, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 12: Charles River Laboratories International, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 13: Charles River Laboratories International, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Charles River Laboratories International, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Zavante Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Zavante Therapeutics Inc (Zavante), formerly SG Pharmaceuticals Inc is a developer of novel therapies for the treatment of infectious diseases. The company offers drugs for the treatment of diseases that affect patients in the hospital setting. Its lead product candidate ZOLYD, is an investi …
  • Micell Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Micell Technologies Inc (Micell) is a medical device company that develops drug delivery systems for the treatment of cardiovascular diseases. The company provides product such as MiStent sirolimus eluting absorbable polymer coronary stent system, a drug-eluting stent that is designed to opt …
  • Callon Petroleum Co (CPE):石油・ガス:M&Aディール及び事業提携情報
    Summary Callon Petroleum Co (CPC) is an oil and gas company that offers building reserves and production of onshore and offshore oil and natural gas. The company carries out acquisition, development, exploration, and exploitation of unconventional onshore, oil, and natural gas reserves. It operates …
  • ADInstruments Pty Ltd:企業の戦略的SWOT分析
    ADInstruments Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Mulberry Group PLC (MUL):企業の財務・戦略的SWOT分析
    Mulberry Group PLC (MUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Merck & Co Inc (MRK):企業の財務・戦略的SWOT分析
    Merck & Co Inc (MRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Daqo New Energy Corp (DQ):電力:M&Aディール及び事業提携情報
    Summary Daqo New Energy Corp (Daqo Cayman) is a manufacturer of polysilicon and solar wafers. Through tolling agreements, the company also offers wafer original equipment manufacturer (OEM) services to external customers. It sells its products to solar cell and solar module manufacturers. Daqo Cayma …
  • X4 Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary X4 Pharmaceuticals Inc (X4 Pharma) is a clinical stage biotechnology company that develops novel therapeutics to treat cancer and rare diseases. The company’s lead drug candidate, X4P-001-LD, is in Phase 2/3 trial used for the treatment for patients with WHIM and other immunodeficiencies. It …
  • PZ Cussons Nigeria Plc:企業の戦略・SWOT・財務情報
    PZ Cussons Nigeria Plc - Strategy, SWOT and Corporate Finance Report Summary PZ Cussons Nigeria Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Axalta Coating Systems Ltd:企業の戦略・SWOT・財務情報
    Axalta Coating Systems Ltd - Strategy, SWOT and Corporate Finance Report Summary Axalta Coating Systems Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Suncor Energy Inc (SU):企業の財務・戦略的SWOT分析
    Suncor Energy Inc (SU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Nidek Co Ltd:製品パイプライン分析
    Summary Nidek Co Ltd (Nidek) is a medical device company that designs, manufactures, distributes and leases ophthalmic and diagnostic equipment. Its products category encompasses ophthalmology and optometry software for advanced angioscan; lens edging technology for manufacturing eyeglasses, and sem …
  • DFDS AS (DFDS):企業の財務・戦略的SWOT分析
    DFDS AS (DFDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Trammo Inc.:戦略・SWOT・企業財務分析
    Trammo Inc. - Strategy, SWOT and Corporate Finance Report Summary Trammo Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999):企業の財務・戦略的SWOT分析
    China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the …
  • Chick-fil-A Inc:企業の戦略・SWOT・財務情報
    Chick-fil-A Inc - Strategy, SWOT and Corporate Finance Report Summary Chick-fil-A Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • HiberGene Diagnostics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary HiberGene Diagnostics Ltd (HiberGene Diagnostics) is a medical equipment company that manufactures, develops and markets molecular diagnostic tests for human infectious diseases using the LAMP technology. The company’s products include HG C. Difficile, HG Meningococcus, HG Group B Streptococ …
  • ClubCorp Holdings Inc:企業のM&A・事業提携・投資動向
    ClubCorp Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ClubCorp Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Repsol SA Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Repsol SA Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Repsol SA (Repsol) is an integrated oil and gas company. It has presence across the entire value chain: exploration and production, transformation, development and marketing of energy. The company’s upstre …
  • Biocodex Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Biocodex Inc (Biocodex), a subsidiary of Biocodex, is a pharmaceutical company that manufacturs and distributs probiotic drug products. The company provides products such as Saccharomyces boulardii CNCM I-745 that has a positive effect on the gut's microflora. It also provides Florastor, a y …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆